What You Should Know:
- Pangea Biomed, the startup behind the advanced cancer response prediction platform ENLIGHT, today announced the beginning of a pilot collaboration with the Knight Cancer Institute at Oregon Health and Science University (OHSU).
- This collaboration will explore the ability to predict personalized cancer treatment response using data processed through the Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Clinical Trials
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
How A Human-AI Partnership Can Boost Clinical Trial Recruitment
The demand for clinical trial testing is rising, from over 260,000 trials conducted in 2018 to nearly double that figure in 2024. This means that more trials are being conducted simultaneously than ever—a factor that adds to the already challenging process of finding clinical trial participants.
Because trial sponsors are struggling to find sufficient numbers of suitable participants, 80% of the world’s more than 450,000 clinical trials are at risk of
Read More
Combining an Omnichannel Strategy with Benchmarking and Metrics to Engage Healthcare Professionals
A critical aspect of any pharma/life sciences commercialization strategy is to develop and deploy effective and meaningful ways to engage, inform and build trust with healthcare providers (HCPs). A brand can best meet its clinical and commercial objectives throughout its lifecycle by offering a well-orchestrated mix of information and resources in different digital and in-person formats that HCPs can easily access.
As with any multifaceted marketing and commercialization strategy, brand
Read More
ixlayer Launches At-Home CBC Testing for Direct-to-Patient Biopharma Programs
What You Should Know:
- xlayer, the leading cloud-based platform powering an end-to-end direct-to-patient (DTP) healthcare experience, announced availability of a Complete Blood Count (CBC) test with at-home sample collection. This move supports biopharma partners who want to accelerate virtual care and reduce barriers to care for patients.
- Available through ixEngage, ixlayer’s DTP biopharma solution, biopharma companies can develop programs to include a CBC test,
Read More
Ontada Transforms Unstructured Oncology Data with Microsoft Azure AI
What You Should Know:
- Ontada, a McKesson business specializing in oncology real-world data and evidence, has formed a strategic partnership with Microsoft to leverage the power of Azure AI in transforming cancer care.
- The partnership will harness the capabilities of Azure OpenAI Service to efficiently process vast amounts of unstructured oncology data, unlocking valuable insights and ultimately improving patient outcomes.
The Challenge of Unstructured Data in
Read More
Phenomix Sciences, InformedDNA Integrate to Advance Genetics-Driven Obesity Care
What You Should Know:
- Phenomix Sciences, a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces a new partnership to advance precision medicine in obesity with InformedDNA, the nation’s leading applied genomics solutions company.
- The collaboration integrates Phenomix’s MyPhenomeTM genetic obesity test with InformedDNA’s DNAimpactTM precision health platform, broadening access to genetics-based weight management care for
Read More
Honeywell, Salesforce Partner to Improve Outcomes in Life Sciences
What You Should Know:
- Honeywell (Nasdaq: HON) today announced the expansion of its strategic partnership with Salesforce, Inc. to deliver a comprehensive platform of software solutions for the life sciences industry.
- The platform—which includes Honeywell’s TrackWise Quality, Salesforce Life Sciences Cloud, Agentforce, and other solutions—will help pharmaceutical and medical technology companies deliver critical medications and healthcare devices to patients more quickly, safely, and
Read More
Myriad Genetics, Flatiron Health Integrates Genetic Testing into OncoEMR
What You Should Know:
- Myriad Genetics, a leader in genetic testing and precision medicine, has announced a collaboration with Flatiron Health, a healthcare technology company focused on oncology solutions, to integrate Myriad's MyRisk® Hereditary Cancer Test into Flatiron's OncoEMR® platform.
- This integration will streamline the process of ordering and reviewing genetic testing results for clinicians within Flatiron's network of community-based cancer care providers.
Improving
Read More
Best Practices for Conquering Data Management Challenges in the Pharma Industry
Managing data effectively can be challenging in any context. But it's especially difficult in an industry like pharmaceuticals, due both to the sensitivity of the data and the severity of consequences that result from data management mistakes.
What can pharma companies do to implement an effective data management strategy? There are no simple answers, but as I explain below, there are best practices that can help optimize the way pharmaceutical businesses collect, integrate, analyze and store
Read More
Cytovale Secures $100M to Expand Commercialization of FDA-Cleared Sepsis Test
What You Should Know:
- Cytovale, a medical diagnostics company revolutionizing early disease detection secures $100M in Series D funding round led by Sands Capital with participation from new investor Canada Pension Plan Investment Board (CPP Investments) and existing investors.
- The investment will fuel the expansion of Cytovale's innovative sepsis diagnostic, IntelliSep, to more hospital emergency departments (EDs) and health systems nationwide.
IntelliSep:
Read More
